Absci Corp (ABSI)

$11.62 +0.51 (4.59%)
Market Cap 1.81B
Revenue (ttm) 2.80M
Net Income (ttm) -115.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,113.57%
Debt to Equity Ratio 0.00
Volume 5,278,700
Avg Vol 6,378,014
Day's Range N/A - N/A
Shares Out 155.91M
Stochastic %K 91%
Beta 2.32
Analysts Strong Sell
Price Target $12.80

Company Profile

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
flam70
flam70 Jul. 3 at 5:45 PM
$ABSI https://www.linkedin.com/posts/ai-drugdiscovery-generativeai-ugcPost-7477419278787457024-b1BF?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAANo6pQBCIF-Wc4f2krmT0uqAEWRN9CcBfE&utm_campaign=whatsapp
0 · Reply
WINNINGWEEZER
WINNINGWEEZER Jul. 3 at 10:23 AM
$ABSI https://finance.yahoo.com/markets/stocks/articles/heres-why-absci-corporation-absi-160004837.html💪🏾🍷
0 · Reply
MorganHoratio
MorganHoratio Jul. 2 at 11:29 PM
One of the strongest sectors outside of AI right now is Biotech. Drug Discovery $TWST Twist Bioscience $ABSI Absci $RXRX Recursion $ABCL AbCellera $NRIX Nurix Therapeutics Smart money is pivoting to the ultimate AI crossover: Drug Discovery & TechBio! This sector captures AI’s efficiency boom without the tech sector’s valuation bubble. DNA giant TWST is absolutely ripping, up over 200% this year to fresh historical highs on strong revenue growth. Protein degradation leader NRIX also just smashed 52-week highs. Alongside Nvidia-backed RXRX, ABSI, and ABCL, this sector is using AI algorithms to shatter traditional pharma limits. Can AI Biotech outpace pure tech in H2? Which ticker is your top play: TWST, ABSI, RXRX, ABCL, or NRIX? Drop your picks below! 👇
0 · Reply
G101SPM
G101SPM Jul. 2 at 5:00 PM
$ABSI $11.36 bid. Holding long position at $2.81 https://stocktwits.com/G101SPM/message/611406142 CHANGE EXIT TO $20.00
0 · Reply
flam70
flam70 Jul. 2 at 12:34 PM
$ABSI truist raised price target to $17 from. $11
1 · Reply
OB1_Whale
OB1_Whale Jul. 1 at 6:36 PM
$ABSI literally every stock I buy it immediately drops 10%.
2 · Reply
QuietLattice
QuietLattice Jul. 1 at 3:05 PM
$ABSI
0 · Reply
OB1_Whale
OB1_Whale Jun. 30 at 10:46 PM
$ABSI just added $120K  come on no whammy
0 · Reply
WINNINGWEEZER
WINNINGWEEZER Jun. 30 at 8:52 PM
$ABSI I'll take it!!! Tomorrow is another battle let's see what it do so far so good💪🏾🍷
0 · Reply
QuietLattice
QuietLattice Jun. 30 at 1:34 PM
$ABSI 6 green day tags in a row. tagged +3.4% early, vol only ~2x. drift > fireworks imo
1 · Reply
Latest News on ABSI
Healthcare stocks have become a haven for investors ditching tech

Jun 26, 2026, 2:39 PM EDT - 7 days ago

Healthcare stocks have become a haven for investors ditching tech

ABBV APGE JNJ LLY MRNA SNY XBI

Absci price target raised to $10 from $4.10 at Morgan Stanley

2026-06-25T10:50:47.000Z - 9 days ago

Absci price target raised to $10 from $4.10 at Morgan Stanley

Absci price target raised to $16 from $8 at H.C. Wainwright

2026-06-25T10:06:19.000Z - 9 days ago

Absci price target raised to $16 from $8 at H.C. Wainwright

Absci prices 13.5M shares at $7.41 in public offering

2026-06-24T10:40:14.000Z - 10 days ago

Absci prices 13.5M shares at $7.41 in public offering

Absci reports Phase 1 data from human trial of ABS-201

2026-06-24T10:35:24.000Z - 10 days ago

Absci reports Phase 1 data from human trial of ABS-201

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

Jun 24, 2026, 6:35 AM EDT - 10 days ago

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

Jun 24, 2026, 6:30 AM EDT - 10 days ago

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

Absci price target raised to $15 from $10 at Guggenheim

2026-06-15T10:40:07.000Z - 19 days ago

Absci price target raised to $15 from $10 at Guggenheim

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

Jun 12, 2026, 9:00 AM EDT - 22 days ago

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

HYFT

Absci Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 3:20 PM EDT - 24 days ago

Absci Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Absci Slides: FY 2026

Jun 9, 2026, 3:20 PM EDT - 24 days ago

Absci Slides: FY 2026

Absci Transcript: AGM 2026

Jun 4, 2026, 9:00 AM EDT - 4 weeks ago

Absci Transcript: AGM 2026

Absci initiated with an Outperform at Leerink

2026-06-04T10:38:54.000Z - 4 weeks ago

Absci initiated with an Outperform at Leerink

Absci Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 7:35 AM EDT - 4 weeks ago

Absci Transcript: Jefferies Global Healthcare Conference 2026

Absci Slides: FY 2026

Jun 3, 2026, 7:35 AM EDT - 4 weeks ago

Absci Slides: FY 2026

Absci initiated with a Buy at BTIG

2026-05-28T11:20:41.000Z - 5 weeks ago

Absci initiated with a Buy at BTIG

Absci to Participate in Upcoming Investor Conferences

May 20, 2026, 8:00 AM EDT - 6 weeks ago

Absci to Participate in Upcoming Investor Conferences

Absci price target lowered to $4.10 from $4.20 at Morgan Stanley

2026-05-14T17:07:20.000Z - 7 weeks ago

Absci price target lowered to $4.10 from $4.20 at Morgan Stanley

Absci price target raised to $11 from $9 at JonesResearch

2026-05-13T08:40:11.000Z - 7 weeks ago

Absci price target raised to $11 from $9 at JonesResearch

Absci reports Q1 EPS (19c), consensus (20c)

2026-05-07T22:23:30.000Z - 2 months ago

Absci reports Q1 EPS (19c), consensus (20c)

Absci Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Absci Earnings Call Transcript: Q1 2026

Absci Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Absci Earnings release: Q1 2026

Absci Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Absci Quarterly report: Q1 2026

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

May 7, 2026, 4:05 PM EDT - 2 months ago

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

Absci Slides: Corporate presentation

May 7, 2026, 4:00 PM EDT - 2 months ago

Absci Slides: Corporate presentation

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 4, 2026, 8:11 PM EDT - 2 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Apr 23, 2026, 4:05 PM EDT - 2 months ago

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Absci Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Absci Proxy statement: Proxy filing

Absci Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Absci Proxy statement: Proxy filing

Absci Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 16, 2026, 1:30 PM EDT - 2 months ago

Absci Transcript: 25th Annual Needham Virtual Healthcare Conference

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

2026-03-25T11:35:46.000Z - 3 months ago

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

Absci Earnings Call Transcript: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 3 months ago

Absci Earnings Call Transcript: Q4 2025

Absci Annual report: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 3 months ago

Absci Annual report: Q4 2025

Absci Earnings release: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 3 months ago

Absci Earnings release: Q4 2025

Absci reports Q4 EPS (20c), consensus (17c)

2026-03-24T20:13:40.000Z - 3 months ago

Absci reports Q4 EPS (20c), consensus (17c)

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 24, 2026, 4:05 PM EDT - 3 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Absci Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 10:00 AM EDT - 4 months ago

Absci Transcript: Leerink Global Healthcare Conference 2026

Absci appoints Ransi Somaratne as CMO

2026-03-03T13:10:19.000Z - 4 months ago

Absci appoints Ransi Somaratne as CMO

VRTX

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Mar 3, 2026, 8:00 AM EST - 4 months ago

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 9:10 AM EST - 4 months ago

Absci Transcript: TD Cowen 46th Annual Health Care Conference

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Feb 24, 2026, 8:00 AM EST - 4 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 6 months ago

Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference

Absci Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 6 months ago

Absci Slides: 44th Annual J.P. Morgan Healthcare Conference

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:00 AM EST - 7 months ago

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Absci Transcript: Status Update

Dec 11, 2025, 10:00 AM EST - 7 months ago

Absci Transcript: Status Update

Absci Press release: Status Update

Dec 11, 2025, 10:00 AM EST - 7 months ago

Absci Press release: Status Update

Absci Slides: Status Update

Dec 11, 2025, 10:00 AM EST - 7 months ago

Absci Slides: Status Update

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Dec 11, 2025, 8:00 AM EST - 7 months ago

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Dec 10, 2025, 8:00 AM EST - 7 months ago

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Dec 4, 2025, 8:00 AM EST - 7 months ago

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Absci Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 4:30 AM EST - 8 months ago

Absci Transcript: Jefferies London Healthcare Conference 2025

Absci Slides: FY 2025

Nov 18, 2025, 4:30 AM EST - 8 months ago

Absci Slides: FY 2025

Absci Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Absci Earnings Call Transcript: Q3 2025

Absci Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Absci Quarterly report: Q3 2025

Absci Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Absci Earnings release: Q3 2025

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 12, 2025, 4:05 PM EST - 8 months ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 10, 2025, 10:00 AM EST - 8 months ago

Absci Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 29, 2025, 4:05 PM EDT - 8 months ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Oct 15, 2025, 8:00 AM EDT - 9 months ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 10 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 9:30 AM EDT - 10 months ago

Absci Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Absci Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 3:20 PM EDT - 10 months ago

Absci Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 11 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Absci Earnings Call Transcript: Q2 2025

Absci Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Absci Quarterly report: Q2 2025

Absci Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Absci Earnings release: Q2 2025

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 11 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Absci Registration statement: Registration Filing

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Absci Registration statement: Registration Filing

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 11 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 1 year ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 1 year ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 1 year ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 8:40 AM EDT - 1 year ago

Absci Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Absci Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 2:00 PM EDT - 1 year ago

Absci Transcript: Jefferies Global Healthcare Conference 2025

Absci Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q1 2025

Absci Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q1 2025

Absci Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Quarterly report: Q1 2025

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 1 year ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Absci Proxy statement: Proxy Filing

Absci Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Absci Proxy statement: Proxy Filing

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 1 year ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 11:45 AM EDT - 1 year ago

Absci Transcript: 24th Annual Needham Virtual Healthcare Conference

Absci Transcript: H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Conference

Apr 2, 2025, 10:30 AM EDT - 1 year ago

Absci Transcript: H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Conference

Absci Registration statement: Registration Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Absci Registration statement: Registration Filing

Absci Transcript: KeyBanc Annual Health Care Forum 2025

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Transcript: KeyBanc Annual Health Care Forum 2025

Absci Slides: FY 2025

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Slides: FY 2025

Absci Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q4 2024

Absci Annual report: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Annual report: Q4 2024

Absci Earnings release: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q4 2024

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 1 year ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 3:10 PM EST - 1 year ago

Absci Transcript: TD Cowen 45th Annual Healthcare Conference

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Absci Transcript: Guggenheim SMID Cap Biotech Conference

Feb 5, 2025, 3:00 PM EST - 1 year ago

Absci Transcript: Guggenheim SMID Cap Biotech Conference

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

Absci Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Absci Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

Absci Slides: FY 2025

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 1 year ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 1 year ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 1 year ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Transcript: R&D Day 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Transcript: R&D Day 2024

Absci Press release: FY 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Press release: FY 2024

Absci Slides: FY 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Slides: FY 2024

Absci Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 1:50 PM EST - 1 year ago

Absci Transcript: Stifel 2024 Healthcare Conference

Absci Transcript: UBS Global Healthcare Conference

Nov 13, 2024, 10:15 AM EST - 1 year ago

Absci Transcript: UBS Global Healthcare Conference

Absci Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings Call Transcript: Q3 2024

Absci Quarterly report: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Quarterly report: Q3 2024

Absci Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings release: Q3 2024

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci Transcript: Guggenheim Inaugural Global Healthcare Conference

Nov 11, 2024, 10:00 AM EST - 1 year ago

Absci Transcript: Guggenheim Inaugural Global Healthcare Conference

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci Transcript: H.C. Wainwright 26th Annual Global Investment Conference

Sep 10, 2024, 11:00 AM EDT - 1 year ago

Absci Transcript: H.C. Wainwright 26th Annual Global Investment Conference

Absci Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 5, 2024, 5:35 PM EDT - 1 year ago

Absci Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Absci Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Earnings Call Transcript: Q2 2024

Absci Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Quarterly report: Q2 2024

Absci Earnings release: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Earnings release: Q2 2024

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 2 years ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 2 years ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 10, 2024, 2:00 PM EDT - 2 years ago

Absci Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 2 years ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Earnings Call Transcript: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings Call Transcript: Q1 2024

Absci Quarterly report: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Quarterly report: Q1 2024

Absci Earnings release: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings release: Q1 2024

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 14, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Absci Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Absci Proxy statement: Proxy Filing

Absci Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Absci Proxy statement: Proxy Filing

Absci Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 8, 2024, 3:00 PM EDT - 2 years ago

Absci Transcript: 23rd Annual Needham Virtual Healthcare Conference

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Absci Annual report: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Absci Annual report: Q4 2023

Absci Earnings release: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Absci Earnings release: Q4 2023

Absci Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 19, 2024, 10:30 AM EDT - 2 years ago

Absci Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Absci Transcript: H.C. Wainwright 1st Annual AI Based Drug Discovery & Development Conference (Virtual)

Mar 7, 2024, 10:30 AM EST - 2 years ago

Absci Transcript: H.C. Wainwright 1st Annual AI Based Drug Discovery & Development Conference (Virtual)

Absci Transcript: KeyBanc’s Emerging Technology Summit

Mar 6, 2024, 12:00 PM EST - 2 years ago

Absci Transcript: KeyBanc’s Emerging Technology Summit

Absci Transcript: TD Cowen 44th Annual Health Care Conference

Mar 4, 2024, 2:10 PM EST - 2 years ago

Absci Transcript: TD Cowen 44th Annual Health Care Conference

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Mar 1, 2024, 4:01 PM EST - 2 years ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Feb 21, 2024, 7:30 AM EST - 2 years ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Absci Transcript: 26th Annual Needham Growth Virtual Conference

Jan 19, 2024, 9:30 AM EST - 2 years ago

Absci Transcript: 26th Annual Needham Growth Virtual Conference

Absci Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 11, 2024, 1:30 PM EST - 2 years ago

Absci Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Absci Slides: FY 2024

Jan 11, 2024, 1:30 PM EST - 2 years ago

Absci Slides: FY 2024

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 10, 2024, 7:30 AM EST - 2 years ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

flam70
flam70 Jul. 3 at 5:45 PM
$ABSI https://www.linkedin.com/posts/ai-drugdiscovery-generativeai-ugcPost-7477419278787457024-b1BF?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAANo6pQBCIF-Wc4f2krmT0uqAEWRN9CcBfE&utm_campaign=whatsapp
0 · Reply
WINNINGWEEZER
WINNINGWEEZER Jul. 3 at 10:23 AM
$ABSI https://finance.yahoo.com/markets/stocks/articles/heres-why-absci-corporation-absi-160004837.html💪🏾🍷
0 · Reply
MorganHoratio
MorganHoratio Jul. 2 at 11:29 PM
One of the strongest sectors outside of AI right now is Biotech. Drug Discovery $TWST Twist Bioscience $ABSI Absci $RXRX Recursion $ABCL AbCellera $NRIX Nurix Therapeutics Smart money is pivoting to the ultimate AI crossover: Drug Discovery & TechBio! This sector captures AI’s efficiency boom without the tech sector’s valuation bubble. DNA giant TWST is absolutely ripping, up over 200% this year to fresh historical highs on strong revenue growth. Protein degradation leader NRIX also just smashed 52-week highs. Alongside Nvidia-backed RXRX, ABSI, and ABCL, this sector is using AI algorithms to shatter traditional pharma limits. Can AI Biotech outpace pure tech in H2? Which ticker is your top play: TWST, ABSI, RXRX, ABCL, or NRIX? Drop your picks below! 👇
0 · Reply
G101SPM
G101SPM Jul. 2 at 5:00 PM
$ABSI $11.36 bid. Holding long position at $2.81 https://stocktwits.com/G101SPM/message/611406142 CHANGE EXIT TO $20.00
0 · Reply
flam70
flam70 Jul. 2 at 12:34 PM
$ABSI truist raised price target to $17 from. $11
1 · Reply
OB1_Whale
OB1_Whale Jul. 1 at 6:36 PM
$ABSI literally every stock I buy it immediately drops 10%.
2 · Reply
QuietLattice
QuietLattice Jul. 1 at 3:05 PM
$ABSI
0 · Reply
OB1_Whale
OB1_Whale Jun. 30 at 10:46 PM
$ABSI just added $120K  come on no whammy
0 · Reply
WINNINGWEEZER
WINNINGWEEZER Jun. 30 at 8:52 PM
$ABSI I'll take it!!! Tomorrow is another battle let's see what it do so far so good💪🏾🍷
0 · Reply
QuietLattice
QuietLattice Jun. 30 at 1:34 PM
$ABSI 6 green day tags in a row. tagged +3.4% early, vol only ~2x. drift > fireworks imo
1 · Reply
OB1_Whale
OB1_Whale Jun. 30 at 12:30 PM
$ABSI literally every time I buy the stock always drops.
1 · Reply
WINNINGWEEZER
WINNINGWEEZER Jun. 29 at 8:53 PM
$ABSI feeling like a swingers club in here with these crazzzzy swings but she's holding up well....higher highs followed by higher lows keep swinging baby🤞🏽💪🏾🍷
0 · Reply
RhinoRino
RhinoRino Jun. 29 at 3:40 PM
$ABSI
1 · Reply
sogenerous
sogenerous Jun. 29 at 3:01 PM
$ABSI $ABCL phenomenal moves - 2 to 12 and 2 to 8s - both were strong buys in 2-3s and reduces/trims here IMO
1 · Reply
RhinoRino
RhinoRino Jun. 29 at 2:22 PM
$ABSI so tutes can get it for 7.40 but we have to oay 50% more?
1 · Reply
Y007
Y007 Jun. 29 at 2:19 PM
👀 This $SANA setup reminds me of a young $ABSI … 🧨
1 · Reply
Zipcash
Zipcash Jun. 29 at 2:13 PM
$ABSI
0 · Reply
FridayMorningQB
FridayMorningQB Jun. 29 at 12:12 PM
$ABSI I want more but waiting for at least a small dip?!
2 · Reply
Martinrb
Martinrb Jun. 28 at 10:19 PM
$ABSI I’ve been watching this company for a while now, seems to be a great innovation for hair loss and potentially many other drugs, I’m excited to see what the results will be, with that being said i’d like to invest on it but not sure if now is the right time or should i wait till they come out with some results by the end of the year hopefully. What are your thoughts?
1 · Reply
flam70
flam70 Jun. 28 at 6:56 PM
$ABSI https://www.linkedin.com/safety/go/?url=https%3A%2F%2Fyoutube%2Ecom%2Fwatch%3Fv%3DCXY8QgP6aNc%26si%3D7gIp2E8Kw0TpFZ-4&urlhash=9h6P&mt=HUD5vklaryhE5XlO2ugKc--6x4JUKbvxwJsEPHrOgIDGBictcpiipuHbfWmOxG5AyEwf9RGw-F1ZYWi0L_0KmOwz0w&isSdui=true
0 · Reply
Zardiw
Zardiw Jun. 27 at 3:58 PM
$BURU - #DDAmanda Chart. Showing up on the scanner. Others on the radar: $ABSI $PTLE $ECHO More charts at: https://DDAmanda.com
0 · Reply
Zardiw
Zardiw Jun. 27 at 3:57 PM
$ILLR - #DDAmanda Chart. Showing up on the scanner. Also keeping an eye on: $BOXL $ABSI $NVCT More charts at: https://DDAmanda.com
0 · Reply